Coronary disease & ACS

Unsupervised phenomapping of perioperative risk in stable coronary artery disease: revealing limitations of the Revised Cardiac Risk Index

Eur J Prev CardiolPublished Retrospective cohort study

Authors' conclusion

Perioperative risk in stable CAD is phenotype-dependent. In this single-center cohort, RCRI performance varied by phenotype and may misclassify risk in clinically important high-risk phenotypes, particularly those characterized by occult ischemia or metabolic dysregulation. CHALSA showed more stable performance across phenotypes

Study context

Population
Patients with stable coronary artery disease (CAD) undergoing elective non-cardiac surgery, 2013–2023
Participants
9,171 patients
Exposure
CHALSA vs Revised Cardiac Risk Index (RCRI) for perioperative major adverse cardiovascular events (MACE) prediction
Outcome
Perioperative MACE:
  • Discrimination of RCRI and CHALSA
  • Overall
  • By phenotype
Methodological detailssingle-centre, unsupervised machine learning phenomapping
  • Single-centre
  • Unsupervised machine learning phenomapping

Main finding

As reported in the abstract

Discrimination for perioperative MACE, overall
GroupAUROC
CHALSA0.816
RCRI0.711

AUROC

CHALSA0.816
RCRI0.711
  • CHALSA vs RCRI: P < 0.001 — 0.816 vs 0.711
Overall perioperative MACE
514 (5.6%)
Six phenotypes identified; MACE incidence range
1.0% to 16.4%

Observational data: associations, not effects.

Further findings

Incremental discrimination of CHALSA over RCRI, by phenotype

Non-revascularized Ischemia ΔAUROC
0.221
Severe Metabolic Burden ΔAUROC
0.264
Stable Revascularized ΔAUROC
0.205
Low-Risk ΔAUROC
0.172
Ischemic HF ΔAUROC
0.086
Elderly Frailty ΔAUROC
0.142

Original publication

Unsupervised phenomapping of perioperative risk in stable coronary artery disease: revealing limitations of the Revised Cardiac Risk Index. Eur J Prev Cardiol. Published 24 March 2026. doi:10.1093/eurjpc/zwag169

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.